Search

Your search keyword '"Ghoussaini, Maya"' showing total 448 results

Search Constraints

Start Over You searched for: Author "Ghoussaini, Maya" Remove constraint Author: "Ghoussaini, Maya"
448 results on '"Ghoussaini, Maya"'

Search Results

1. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

2. Mapping interindividual dynamics of innate immune response at single-cell resolution

4. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

6. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

7. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.

8. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

9. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

10. Correction: Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

11. An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci

12. Association analysis identifies 65 new breast cancer risk loci

13. A map of transcriptional heterogeneity and regulatory variation in human microglia

15. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

16. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

17. Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

18. Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).

19. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

20. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

21. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

22. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

23. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

24. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.

27. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.

28. Large-scale genotyping identifies 41 new loci associated with breast cancer risk

29. Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers

30. Genome-wide association analysis identifies three new breast cancer susceptibility loci

31. Systematic disease-agnostic identification of therapeutically actionable targets using the genetics of human plasma proteins

32. Supplementary Table 1 from Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk

33. Data from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

34. Supplementary Table 3 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

35. Supplementary Table 2 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

36. Supplementary Table Legend from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

37. Supplementary Table 1 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

38. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

39. The next-generation Open Targets Platform: reimagined, redesigned, rebuilt

40. Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity

42. Multi-Ancestry Mendelian Randomization of Omics Traits Revealing Putative Drug Targets of COVID-19 Severity

43. Mapping interindividual dynamics of innate immune response at single-cell resolution

44. Loss-of-function mutations in SIM1 contribute to obesity and Prader-Willi--like features

45. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance

46. Author response: A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance

47. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

48. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

49. Publisher Correction : Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

50. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

Catalog

Books, media, physical & digital resources